CURRENT
ISSUE
1586

This issue includes reviews of drugs for glaucoma, age-related macular degeneration (AMD), bacterial conjunctivitis, and dry eye disease. Allergic conjunctivitis is reviewed in a separate issue.1

In general, all eye drops should be given in doses of one drop. The average volume of a single drop is larger than the eyelid's capacity to hold fluid; a second drop only washes out the first, may increase systemic absorption, and doubles the cost of treatment. The interval between instillation of 2 different drops should be at least 5 minutes. Patients who experience stinging or burning following...  Continue reading

More from Issue 1586
Previous Issue: 1585      November 18, 2019
Coming Soon
Trifarotene (Aklief) - A New Topical Retinoid for Acne
Brolucizumab (Beovu) for Age-Related Macular Degeneration
Elexacaftor/Tezacaftor/Ivacaftor (Trikafta) for Cystic Fibrosis
Letermovir (Prevymis) for CMV Prophylaxis
Search
Donate
Subscribe
Conversation
Follow us   Twitter LinkedIn YouTube Blog RSS   Email Alerts
 Tweets
Featured Article
FROM
ISSUE
1585
Cannabis (marijuana) contains more than 60 pharmacologically active cannabinoids; delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) are the best known. THC is the main psychoactive constituent of cannabis. CBD, unlike THC, does not produce intoxication or euphoria. ... Continue reading